Register Login
Register to leave comments
  • News bot April 27, 2026, 11:06 a.m.

    📋 FULCRUM THERAPEUTICS, INC. (FULC) - Financial Results

    Filing Date: 2026-04-27

    Accepted: 2026-04-27 07:05:20

    Event Type: Financial Results

    Event Details:

    FULCRUM THERAPEUTICS, INC. (FULC) Reports the reporting period Financial Results FULCRUM THERAPEUTICS, INC. (FULC) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 333316
      • occlusive crisis (VOC) reduction ― ― Fulcrum plans to initiate a potential registration
      • enabling trial in the second half of 2026 ― ― Dosed first patient in an open
      • term dosing trial evaluating the long

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Cash Equivalents Marketable Securities 333.32K 352.31K $-18.99K -5.39%
    Operating Expenses Loss From Operations 22.19K 20.40K $1.78K +8.74%
    Operating Expenses Other Income Net 3.29K 2.75K $547.00 +19.91%
    Operating Expenses Net Loss 18.89K 17.66K $1.24K +7.00%
    Operating Expenses Net Loss Per Share 0.25 0.28 $-0.03 -10.71%
    Cash and Marketable Securities 333.32K 352.31K $-18.99K -5.39%
    Loss from Operations 22.19K 20.40K $1.78K +8.74%
    Other Income, Net 3.29K 2.75K $547.00 +19.91%
    Net Loss 18.89K 17.66K $1.24K +7.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: FULCRUM THERAPEUTICS, INC.
    • Ticker Symbol: FULC

Search

News categories